JOHNSON & JOHNSON RAPP Holdings History
JOHNSON & JOHNSON's Rapport Therapeutics Inc Holding Summary
As of 2025-06-30, JOHNSON & JOHNSON held 2.50 Mil shares of Rapport Therapeutics Inc(RAPP), totaling $28.55 Mil. This investment constitutes 8.55% of their stock portfolio, and JOHNSON & JOHNSON now holds 6.84% of the outstanding Rapport Therapeutics Inc(RAPP) stock.
The initial trade took place in 2024Q2. And since then JOHNSON & JOHNSON has made 1 purchases of RAPP, at an average price of $23.15, for a total of 2.50 Mil shares. Based on historical transaction data and RAPP's current price of $15.50, JOHNSON & JOHNSON's estimated gain on his RAPP holdings is $-19.11 Mil, reflecting a -33.05% gain to date.
JOHNSON & JOHNSON RAPP ($15.50) Holding Chart
JOHNSON & JOHNSON RAPP ($15.50) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
